medmix AG (MEDX) — Capital Reinvestment Ratio
medmix AG (MEDX) has a Capital Reinvestment Ratio of 0.50x as of December 2025, meaning it reinvests 1% of its operating cash flow (CHF37.40 Million) in capital expenditures (CHF18.80 Million). Check medmix AG tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
medmix AG Capital Reinvestment Ratio (2018–2025)
This chart tracks medmix AG's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does medmix AG generate cash.
Annual Capital Reinvestment Ratio for medmix AG (2018–2025)
Year-by-year Capital Reinvestment Ratio for medmix AG from 2018 to 2025. See medmix AG (MEDX) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.51x | CHF67.80 Million | CHF34.50 Million | ▼ -9.1% |
| 2024 | 0.56x | CHF86.60 Million | CHF48.50 Million | ▼ -40.6% |
| 2023 | 0.94x | CHF56.10 Million | CHF52.90 Million | ▲ +16.3% |
| 2022 | 0.81x | CHF47.60 Million | CHF38.60 Million | ▲ +121.9% |
| 2021 | 0.37x | CHF87.30 Million | CHF31.90 Million | ▼ -57.1% |
| 2020 | 0.85x | CHF50.60 Million | CHF43.10 Million | ▲ +109.7% |
| 2019 | 0.41x | CHF89.10 Million | CHF36.20 Million | ▲ +27.6% |
| 2018 | 0.32x | CHF94.20 Million | CHF30.00 Million | — |